Compare Bio Protocol (BIO) vs Newton Protocol (NEWT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Newton Protocol — how do they compare? Bio Protocol trades at Rp516.9 (market cap Rp1,15T, Rp264,79M 24h volume), while Newton Protocol trades at Rp842.72 (market cap Rp245,97M, Rp109,31M 24h volume). The key difference: Bio Protocol is far larger — about 4675.4× Newton Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 293,6M / 1B NEWT (30%) for Newton Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Newton Protocol for 24 Days on average.
| BIO | NEWT | |
|---|---|---|
Market Cap | Rp1,15T | Rp245,97M |
Volume (24h) | Rp264,79M | Rp109,31M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 293,6M / 1B NEWT (30%) |
Typical Hold Time | 16 Days | 24 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Newton Protocol (NEWT) is currently trading at Rp842.93 with a market cap of Rp245.97 million, showing a bearish technical signal overall. The asset trades near support at Rp837, with moving averages indicating a sell bias while oscillators are neutral. RSI_6 at 25.71 suggests potential oversold conditions. Recent news highlights strategic alliances and platform integrations, though on-chain activity remains limited. The token's circulating supply is 293.6 million NEWT out of a max 1 billion, with a 30% circulation rate and average hold time of 24 days.
Outlook remains cautious due to bearish technicals and low liquidity. Key opportunities include potential oversold bounce from support and ecosystem growth from recent partnerships. Major risks include high volatility, limited exchange depth, and regulatory uncertainty common to small-cap crypto assets. Investors should monitor volume changes and key support breaks.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Newton Protocol
The Newton Protocol serves as a verifiable automation layer for on-chain finance, enabling users to delegate complex, cross-chain actions to AI agents while ensuring that each step adheres to user-DeFined guidelines through cryptographic guarantees. It combines smart accounts, such as ERC-4337 and EIP-7702, to allow for detailed delegation, along with trusted execution environment (TEE) attestations and zero-knowledge proofs (ZKPs) to verify the correctness of every off-chain decision. The ultimate aim is to transform automation into a trust-minimized framework, thereby facilitating agentic finance across multiple blockchains.
Read more on NEWT →
